Zobrazit minimální záznam

dc.contributor.authorPetejová, Naděžda
dc.contributor.authorMartínek, Arnošt
dc.contributor.authorZadražil, Josef
dc.contributor.authorKlementa, Viktor
dc.contributor.authorPřibylová, Lenka
dc.contributor.authorBriš, Radim
dc.contributor.authorKáňová, Marcela
dc.contributor.authorŠigutová, Radka
dc.contributor.authorKacířová, Ivana
dc.contributor.authorŠvagera, Zdeněk
dc.contributor.authorBače, Eva
dc.contributor.authorStejskal, David
dc.date.accessioned2022-06-15T11:43:54Z
dc.date.available2022-06-15T11:43:54Z
dc.date.issued2022
dc.identifier.citationBMC Nephrology. 2022, vol. 23, issue 1, art. no. 111.cs
dc.identifier.issn1471-2369
dc.identifier.urihttp://hdl.handle.net/10084/146281
dc.description.abstractBackground: Through regulation of signaling pathways, microRNAs (miRNAs) can be involved in sepsis and associated organ dysfunction. The aims of this study were to track the 7-day time course of blood miRNAs in patients with sepsis treated with vancomycin, gentamicin, or a non-nephrotoxic antibiotic and miRNA associations with neutrophil gelatinase-associated lipokalin (NGAL), creatinine, procalcitonin, interleukin-6, and acute kidney injury (AKI) stage. Methods: Of 46 adult patients, 7 were on vancomycin, 20 on gentamicin, and 19 on another antibiotic. Blood samples were collected on days 1, 4, and 7 of treatment, and miRNAs were identified using quantitative reverse transcription PCR. Results: The results showed no relationship between miRNA levels and biochemical variables on day 1. By day 7 of gentamicin treatment miR-15a-5p provided good discrimination between AKI and non-AKI (area under curve, 0.828). In patients taking vancomycin, miR-155-5p and miR-192-5p positively correlated with creatinine and NGAL values, and miR-192-5p and miR-423-5p positively correlated with procalcitonin and interleukin-6 in patients treated with a nonnephrotoxic antibiotic. In patients together we found positive correlation between miR-155-5p and miR-423-5p and all biochemical markers. Conclusion: The results suggest that these four miRNAs may serve as diagnostic or therapeutic tool in sepsis, renal injury and nephrotoxic treatment.cs
dc.language.isoencs
dc.publisherSpringer Naturecs
dc.relation.ispartofseriesBMC Nephrologycs
dc.relation.urihttps://doi.org/10.1186/s12882-022-02726-6cs
dc.rightsCopyright © 2022, The Author(s)cs
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/cs
dc.subjectacute kidney injurycs
dc.subjectgentamicincs
dc.subjectmicroRNAcs
dc.subjectnephrotoxicitycs
dc.subjectsepsiscs
dc.subjectvancomycincs
dc.titleExpression and 7-day time course of circulating microRNAs in septic patients treated with nephrotoxic antibiotic agentscs
dc.typearticlecs
dc.identifier.doi10.1186/s12882-022-02726-6
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume23cs
dc.description.issue1cs
dc.description.firstpageart. no. 111cs
dc.identifier.wos000770762200002


Soubory tohoto záznamu

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam

Copyright © 2022, The Author(s)
Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je Copyright © 2022, The Author(s)